ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Ophthalmology

Top Ophthalmology Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT BAHR MD

Ophthalmology

4,871

$326K

764
716 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 50%

$67
Average prescription price

Avg: $60

THOMAS LANG MD

Ophthalmology

4,645

$248K

746
702 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 50%

$53
Average prescription price

Avg: $60

PAUL KOCH M.D.

Ophthalmology

4,618

$205K

1078
985 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

32%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 50%

$44
Average prescription price

Avg: $60

JOSEPH DUCHARME M.D.

Ophthalmology

3,543

$213K

473
434 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

49%
prescriptions for brand name drugs

Avg: 50%

$60
Average prescription price

Avg: $60

MICHAEL MOTOLKO M.D.

Ophthalmology

2,489

$210K

330
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

66%
prescriptions for brand name drugs

Avg: 50%

$84
Average prescription price

Avg: $60

ELLIOT PERLMAN MD

Ophthalmology

2,439

$140K

479
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

57%
prescriptions for brand name drugs

Avg: 50%

$58
Average prescription price

Avg: $60

CHRISTOPHER NEWTON MD

Ophthalmology

2,429

$159K

542
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 50%

$65
Average prescription price

Avg: $60

WILLIAM ANDREONI OPHTHALMOLOGIST

Ophthalmology

2,310

$174K

520
486 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 50%

$75
Average prescription price

Avg: $60

DUGALD MUNRO MD

Ophthalmology

2,282

$121K

321
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 50%

$53
Average prescription price

Avg: $60

GIULIO DIAMANTE MD

Ophthalmology

2,236

$130K

481
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

56%
prescriptions for brand name drugs

Avg: 50%

$58
Average prescription price

Avg: $60

SAFA WAGDI MD

Ophthalmology

2,154

$105K

351
326 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 50%

$49
Average prescription price

Avg: $60

CHARLES LANZILLO

Ophthalmology

2,082

$160K

405
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 50%

$77
Average prescription price

Avg: $60

S. MURPHY M.D.

Ophthalmology

2,004

$143K

275
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

57%
prescriptions for brand name drugs

Avg: 50%

$71
Average prescription price

Avg: $60

DONALD FARGNOLI M.D.

Ophthalmology

1,929

$91.2K

339
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 50%

$47
Average prescription price

Avg: $60

LAWRENCE EHRLICH M.D.

Ophthalmology

1,885

$108K

314
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 50%

$57
Average prescription price

Avg: $60

ALFRED PAUL MD

Ophthalmology

1,736

$90.2K

322
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 50%

$52
Average prescription price

Avg: $60

ELEFTHERIOS ALEXANDROU M.D.

Ophthalmology

1,724

$104K

377
341 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

23%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

40%
prescriptions for brand name drugs

Avg: 50%

$60
Average prescription price

Avg: $60

CHRISTOPHER WAY MD

Ophthalmology

1,597

$88.6K

214
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

41%
prescriptions for brand name drugs

Avg: 50%

$56
Average prescription price

Avg: $60

WILLIAM VARR M.D.

Ophthalmology

1,580

$82.4K

313
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

51%
prescriptions for brand name drugs

Avg: 50%

$52
Average prescription price

Avg: $60

THOMAS LEDDY MD

Ophthalmology

1,558

$110K

271
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

57%
prescriptions for brand name drugs

Avg: 50%

$70
Average prescription price

Avg: $60

LIN CHOU MD

Ophthalmology

1,524

$69.4K

320
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

41%
prescriptions for brand name drugs

Avg: 50%

$46
Average prescription price

Avg: $60

DURGA LARKIN M.D.

Ophthalmology

1,452

$132K

340
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

80%
prescriptions for brand name drugs

Avg: 50%

$91
Average prescription price

Avg: $60

CHRISTINE GILL MD

Ophthalmology

1,449

$64.2K

239
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 50%

$44
Average prescription price

Avg: $60

PETER BRASCH MD

Ophthalmology

1,415

$89.4K

276
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

52%
prescriptions for brand name drugs

Avg: 50%

$63
Average prescription price

Avg: $60

DAVID RIVERA M.D.

Ophthalmology

1,379

$84K

213
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 50%

$61
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank